Search

Your search keyword '"Tu, Jianfei"' showing total 300 results

Search Constraints

Start Over You searched for: Author "Tu, Jianfei" Remove constraint Author: "Tu, Jianfei"
300 results on '"Tu, Jianfei"'

Search Results

12. Adjuvant Transarterial Chemoembolization With Sorafenib for Portal Vein Tumor Thrombus

16. Synergy of Oxygen Vacancy and Surface Modulation Endows Hollow Hydrangea-like MnCo 2 O 4.5 with Enhanced Capacitive Performance.

27. MEX3A determines in vivo hepatocellular carcinoma progression and induce resistance to sorafenib in a Hippo-dependent way

28. Monodisperse CaCO3-loaded gelatin microspheres for reversing lactic acid-induced chemotherapy resistance during TACE treatment

29. Nomogram for tumour response based on prospective cohorts of hepatocellular carcinoma patients receiving immunotherapy combined with targeted therapy: development and validation

30. Inactivation of KDM5A suppresses growth and enhances chemosensitivity in liver cancer by modulating ROCK1/PTEN/AKT pathway

31. Adjuvant transarterial chemoembolization with sorafenib for patients with hepatocellular carcinoma with portal vein tumor thrombus after surgery: A phase III, multicenter, randomized, controlled trial.

32. Patch Matching for Few-Shot Industrial Defect Detection

39. Correction to “DNA-Functionalized Liposomes In Vivo Fusion for NIR-II/MRI Guided Pretargeted Ferroptosis Therapy of Metastatic Breast Cancer”

42. DNA-Functionalized Liposomes In Vivo Fusion for NIR-II/MRI Guided Pretargeted Ferroptosis Therapy of Metastatic Breast Cancer

46. Inactivation of KDM5A Suppresses Growth and Enhances Chemosensitivity in Liver Cancer by Modulating ROCK1/PTEN/AKT Pathway

47. Homogenous Multifunctional Microspheres Induce Ferroptosis to Promote the Anti-hepatocarcinoma Effect of Chemoembolization

48. Construction of a novel radiomics nomogram for the prediction of aggressive intrasegmental recurrence of HCC after radiofrequency ablation

49. FGFR2-BICC1: A Subtype Of FGFR2 Oncogenic Fusion Variant In Cholangiocarcinoma And The Response To Sorafenib

50. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation

Catalog

Books, media, physical & digital resources